Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi

Emerging Infectious Diseases

Volumn 13, Issue 6, 2007, Pages 873-877

  Juliano, Jonathan J ^a   Kwiek, Jesse J ^a   Cappell, Kathryn ^a   Mwapasa, Victor ^b   Meshnick, Steven R ^a,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; ANTIMALARIAL AGENT; CARRIER PROTEIN; HETERODUPLEX; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFRICA; ARTICLE; DRUG SENSITIVITY; ENDEMIC DISEASE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE POLICY; HOST; HUMAN; MALARIA; MALAWI; METHODOLOGY; MOLECULAR CLONING; PARASITE; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER GENE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HETERODUPLEX ANALYSIS; MALARIA FALCIPARUM; POINT MUTATION; PREGNANCY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; FEMALE; GENOTYPE; HETERODUPLEX ANALYSIS; HUMANS; MALARIA, FALCIPARUM; MALAWI; MEMBRANE TRANSPORT PROTEINS; NUCLEIC ACID HETERODUPLEXES; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PROTOZOAN PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 34249993729     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1306.061182     Document Type: Article

References (17)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214-7.
2. World Health Organization. Susceptibility of Plasmodium falciparum to antimalarial drugs. Report on global monitoring: 1996-2004. Geneva: The Organization; 2005.
3. Kwiek JJ, Alker AP, Wenink EC, Chaponda M, Kalilani LV, Meshnick SR. Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections. Antimicrob Agents Chemother. 2007;51:521-7.
4. Farnert A, Arez AP, Babiker HA. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg. 2001;95:225-32.
5. Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol. 2005;56:323-33.
6. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg. 2003;68:413-5.
7. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870-5.
8. Wilson PE, Kazadi W, Kamwendo DD, Purfield A, Meshnick SR. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop. 2004;93:97-106.
9. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006;355:1959-66.
10. Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, Molyneux ME, et al. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS. 2006;20:1869-77.
11. Resch W, Parkin N, Stuelke EL, Watkins T, Swanstrom R. A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics. Proc Natl Acad Sci U S A. 2001;98:176-81.
12. Ngrenngarmlert W, Kwiek JJ, Kamwendo DD, Ritola K, Swanstrom R, Wongsrichanalai C, et al. Measuring allelic heterogeneity in Plasmodium falciparum by heteroduplex tracking assay. Am J Trop Med Hyg. 2005;72:694-701.
13. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257-63.
14. Basco LK, Ndounga M, Ngane VF, Soula G. Molecular epidemiology of malaria in Cameroon. XIV. Plasmodium falciparum chloroquine resistance transporter (PFCRT) gene sequences of isolates before and after chloroquine treatment. Am J Trop Med Hyg. 2002;67:392-5.
15. Jafari S, Le Bras J, Bouchaud O, Durand R. Plasmodium falciparum clonal population dynamics during malaria treatment. J Infect Dis. 2004;189:195-203.
16. Kapoor A, Jones M, Shafer RW, Rhee SY, Kazanjian P, Delwart EL. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay. J Virol. 2004;78:7112-23.
17. Mookherjee S, Howard V, Nzila-Mouanda A, Watkins W, Sibley CH. Identification and analysis of dihydrofolate reductase alleles from Plasmodium falciparum present at low frequency in polyclonal patient samples. Am J Trop Med Hyg. 1999;61:131-40.